Treatment of human small cell lung cancer (SCLC) cell with doxorubicin at 50 nM increased c-jun N-terminal kinase (JNK) activity and simultaneously induced a markedly increase in MRP1 expression [30]. The gene discussed is ABCC1; the disease is small cell lung carcinoma.